> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest Federal Register Notices
- URL: https://www.fdaweb.com/latest-federal-register-notices-178/
- Published: 2018-05-06T12:00:00.000Z
- Updated: 2026-09-15T00:02:56.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5141371

[**FDA Withdraws 3 Sun Pharma ANDAs**](https://www.fdaweb.com/fda-withdraws-3-sun-pharma-andas/)  
*Federal Register* notice: FDA withdraws three Sun Pharmaceutical Industries ANDAs because they are no longer marketed. 05/04/2018

[**9 No Longer Marketed ANDAs Withdrawn**](https://www.fdaweb.com/9-no-longer-marketed-andas-withdrawn-3/)  
*Federal Register* notice: FDA withdraws the approval of nine ANDAs from multiple applicants. 05/04/2018

[**Needle Destruction Device Down Classified**](https://www.fdaweb.com/needle-destruction-device-down-classified/)  
*Federal Register* notice: FDA issues a final order to reclassify the needle destruction device into Class 2 (special controls)and subject to premarket notification. 05/04/2018

[**Guide on PDUFA Implementation**](https://www.fdaweb.com/guide-on-pdufa-implementation/)  
*Federal Register* notice: FDA makes available a final guidance entitled “Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017.” 05/03/2018